These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

725 related items for PubMed ID: 20730166

  • 1. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
    Rosenholm JM, Sahlgren C, Lindén M.
    Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
    [Abstract] [Full Text] [Related]

  • 2. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS.
    Small; 2010 Sep 20; 6(18):1952-67. PubMed ID: 20690133
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
    Rosenholm JM, Mamaeva V, Sahlgren C, Lindén M.
    Nanomedicine (Lond); 2012 Jan 20; 7(1):111-20. PubMed ID: 22191780
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mesoporous silica nanoparticles as nanocarriers.
    Wu SH, Hung Y, Mou CY.
    Chem Commun (Camb); 2011 Sep 28; 47(36):9972-85. PubMed ID: 21716992
    [Abstract] [Full Text] [Related]

  • 7. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C, Maris P, Sisci D, Perrotta E, Brunelli E, Perrotta I, Panno ML, Tagarelli A, Versace C, Casula MF, Testa F, Andò S, Nagy JB, Pasqua L.
    Nanoscale; 2011 Aug 28; 3(8):3198-207. PubMed ID: 21725561
    [Abstract] [Full Text] [Related]

  • 8. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X, Wang Y, Peng B.
    Chem Asian J; 2014 Jan 28; 9(1):319-27. PubMed ID: 24115568
    [Abstract] [Full Text] [Related]

  • 9. Nanostructured porous Si-based nanoparticles for targeted drug delivery.
    Shahbazi MA, Herranz B, Santos HA.
    Biomatter; 2012 Jan 28; 2(4):296-312. PubMed ID: 23507894
    [Abstract] [Full Text] [Related]

  • 10. Mesoporous materials for drug delivery.
    Vallet-Regí M, Balas F, Arcos D.
    Angew Chem Int Ed Engl; 2007 Jan 28; 46(40):7548-58. PubMed ID: 17854012
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
    Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VS.
    ACS Nano; 2011 Feb 22; 5(2):1366-75. PubMed ID: 21294526
    [Abstract] [Full Text] [Related]

  • 14. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
    Hartono SB, Gu W, Kleitz F, Liu J, He L, Middelberg AP, Yu C, Lu GQ, Qiao SZ.
    ACS Nano; 2012 Mar 27; 6(3):2104-17. PubMed ID: 22385282
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
    Li X, Xie QR, Zhang J, Xia W, Gu H.
    Biomaterials; 2011 Dec 27; 32(35):9546-56. PubMed ID: 21906804
    [Abstract] [Full Text] [Related]

  • 19. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.
    Li Z, Zhang Y, Feng N.
    Expert Opin Drug Deliv; 2019 Mar 27; 16(3):219-237. PubMed ID: 30686075
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.